Cerity Partners LLC Purchases 116,607 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cerity Partners LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 177.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,195 shares of the medical instruments supplier's stock after acquiring an additional 116,607 shares during the period. Cerity Partners LLC owned about 0.09% of DENTSPLY SIRONA worth $2,722,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of XRAY. Proficio Capital Partners LLC acquired a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $422,000. Raymond James Financial Inc. acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $10,335,000. HighTower Advisors LLC grew its holdings in shares of DENTSPLY SIRONA by 41.3% during the 4th quarter. HighTower Advisors LLC now owns 24,480 shares of the medical instruments supplier's stock valued at $465,000 after acquiring an additional 7,152 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of DENTSPLY SIRONA by 35.8% during the fourth quarter. Sequoia Financial Advisors LLC now owns 11,556 shares of the medical instruments supplier's stock worth $219,000 after acquiring an additional 3,048 shares in the last quarter. Finally, Commonwealth Equity Services LLC boosted its position in DENTSPLY SIRONA by 3,263.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 314,043 shares of the medical instruments supplier's stock valued at $5,961,000 after purchasing an additional 304,707 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded up $0.25 during trading hours on Monday, hitting $15.93. 3,227,113 shares of the company traded hands, compared to its average volume of 2,907,409. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79. The stock has a market capitalization of $3.17 billion, a price-to-earnings ratio of -3.50, a P/E/G ratio of 1.12 and a beta of 0.94. The firm has a 50-day moving average of $16.07 and a 200 day moving average of $16.26. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. During the same quarter last year, the company earned $0.42 earnings per share. The firm's revenue was down 7.8% on a year-over-year basis. On average, analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.02%. The ex-dividend date of this dividend was Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio is -14.10%.

Analyst Upgrades and Downgrades

XRAY has been the subject of a number of recent research reports. Piper Sandler cut their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target on the stock. in a report on Tuesday, April 15th. Finally, Barrington Research increased their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research report on Monday, May 12th. Ten equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and a consensus target price of $19.60.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.